Anaconda Pharma Overview
- Year Founded
-
2003

- Status
-
Acquired/Merged
- Employees
-
7

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$45.7M
Anaconda Pharma General Information
Description
Developer of treatments for infections by human papillomavirus. The company is developing theraputics for the treatment of infections by human papillomavirus, condyloma and related diseases.
Contact Information
Website
www.anacondapharma.comCorporate Office
- Villejuif Bio Park
- 1 mail du Professeur Georges Mathé
- 94800 Villejuif
- France
Corporate Office
- Villejuif Bio Park
- 1 mail du Professeur Georges Mathé
- 94800 Villejuif
- France
Anaconda Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 03-Jun-2015 | $45.7M | Completed | Pre-Clinical Trials | ||
2. Later Stage VC (Series B) | 19-Jul-2010 | Completed | Pre-Clinical Trials | |||
1. Accelerator/Incubator | 01-Nov-2003 | Completed | Startup |
Anaconda Pharma Comparisons
Industry
Financing
Details
Anaconda Pharma Competitors (7)
One of Anaconda Pharma’s 7 competitors is Avalyn Pharma, a Venture Capital-Backed company based in Cambridge, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Avalyn Pharma | Venture Capital-Backed | Cambridge, MA | ||||
Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
Lung Therapeutics | Formerly VC-backed | Austin, TX | ||||
Cardurion | Venture Capital-Backed | Burlington, MA |
Anaconda Pharma Patents
Anaconda Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-3000490-A1 | Process for synthesizing hydrazine useful in the treatment of papilloma virus | Active | 27-Dec-2012 | ||
US-9908858-B2 | Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus | Active | 27-Dec-2012 | ||
US-20150353517-A1 | Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus | Active | 27-Dec-2012 | ||
EP-2938595-B1 | Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus | Inactive | 27-Dec-2012 | ||
EP-2938595-A1 | Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus | Active | 27-Dec-2012 | C07D295/135 |
Anaconda Pharma Signals
Anaconda Pharma Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Aurinvest | Venture Capital | Minority | ||
The Institut Pasteur | Accelerator/Incubator | Minority |
Anaconda Pharma FAQs
-
When was Anaconda Pharma founded?
Anaconda Pharma was founded in 2003.
-
Where is Anaconda Pharma headquartered?
Anaconda Pharma is headquartered in Villejuif, France.
-
What is the size of Anaconda Pharma?
Anaconda Pharma has 7 total employees.
-
What industry is Anaconda Pharma in?
Anaconda Pharma’s primary industry is Biotechnology.
-
Is Anaconda Pharma a private or public company?
Anaconda Pharma is a Private company.
-
What is the current valuation of Anaconda Pharma?
The current valuation of Anaconda Pharma is
. -
What is Anaconda Pharma’s current revenue?
The current revenue for Anaconda Pharma is
. -
How much funding has Anaconda Pharma raised over time?
Anaconda Pharma has raised $3.24M.
-
Who are Anaconda Pharma’s investors?
Aurinvest and The Institut Pasteur have invested in Anaconda Pharma.
-
Who are Anaconda Pharma’s competitors?
Avalyn Pharma, Amgen, Ona Therapeutics, Lung Therapeutics, and Cardurion are some of the 7 competitors of Anaconda Pharma.
-
When was Anaconda Pharma acquired?
Anaconda Pharma was acquired on 03-Jun-2015.
-
Who acquired Anaconda Pharma?
Anaconda Pharma was acquired by Aviragen Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »